Remote healthcare monitoring can promote the realization of individualized treatment goals through the following ways: training patients to manage their own diseases, adopting population-based health care tools, such as individualized education modules and registers, access to electronic decision support tools under the supervision of doctor, and providing timely information and guidance based on individual data and population data.
In the United States, people have great interest in developing remote medical monitoring for diabetes. From a scientific standpoint, the evidence of its benefits is limited. There is a strong suggestion that this approach will help improve outcomes and reduce costs, but there is not enough high-quality data to persuade many payers or patients to pay for this treatment.
At present, many remote medical monitoring products are under development, some of which are only for diabetes, and some of which are for multiple diseases at the same time. With the generalization of the inclusion of multiple disease states, the potential opportunity for patients to be included in the group is greater, but the specificity of each product in managing diabetes is also lower. Specific performance results of multiple products and investigation systems are required to fully understand whether these products can achieve or cannot. Behavior modification research is needed to ensure that the instructions provided in the response generated by remote medical monitoring will be truly implemented. For remote medical monitoring and intervention of diabetes, few economic analyses have been published. Such information is needed to influence health policy makers, who may currently refuse to cover such evolving treatments. As electronic medical records and decision support software become more and more popular, and clinicians and patients gradually become familiar with their advantages and disadvantages, the effectiveness of remote medical monitoring intervention will likely be improved.
TeleRPM BGM Gen 1 has two features: Leading precision: 1.Test strip with single-layer 8-electrode technology 2.HCT correction technology (both test strip and chip) 3.Accuracy results 4.Precision/Repeatability results
Stable connectivity: 1.Cellular connectivity 2.Measured data in the United States 3.Active antenna test efficiency 4.Passive antenna test efficiency comparison (low frequency)
Compared with other diseases, remote medical monitoring is particularly suitable for the treatment of diabetes, because diabetes needs to interpret and predict responses to the various types of data that patients can measure at home. With the progress of communication technology, the emergence of better data management and decision support software, and the satisfaction of payers and regulators with the inherent legislation and liability of this home care method, it is expected that remote medical monitoring for diabetes will be increasingly used. Remote medical monitoring is expected to become a new tool for diabetes medical service providers to communicate with patients in the 21st century to improve medical quality and reduce medical costs.
Founded in 2002, Transtek is committed to multiple health fields such as remote health and chronic disease management, providing customers with medical-grade "RPM devices" and "cloud services". Transtek has established a co-branded solution named TeleRPM since 2022, it stands for Quality & Value which is the best of Transtek. TeleRPM is an integrated solution which includes cellular blood pressure monitor, cellular weight scale, cellular blood glucose meter and all-round BLE package with AnyHub solution.
